Close Menu

This article has been updated to include additional information from the complaint against Myriad Genetics filed in the US District Court for the District of South Carolina.

NEW YORK – Myriad Genetics has entered into a $9.1 million settlement agreement to resolve allegations that it improperly billed Medicare for its hereditary cancer tests, after the US Department of Justice declined to intervene in the matter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.